NCT05041543View on ClinicalTrials.gov

Safety and Tolerability of NTX-101 in Korean Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 2, 2021

Primary Completion Date

June 15, 2021

Study Completion Date

June 15, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

NTX-101

Eye drops, topical administration

DRUG

Placebo

Placebo as eye drops

Trial Locations (1)

47323

Inje University Busan Paik Hospital, Busan

All Listed Sponsors
lead

Pinotbio, Inc.

INDUSTRY

NCT05041543 - Safety and Tolerability of NTX-101 in Korean Healthy Volunteers | Biotech Hunter | Biotech Hunter